Armin Hatzelmann
10Patents
2h-index
38Co-inventors
50Inventor score
Filing activity: Aug 21, 2003 → Aug 29, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6818651B2 | (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors | Chemistry; Metallurgy | 10 | Expired |
| US7838521B2 | 3-oxa-10-aza-phenanthrenes | Human Necessities | 3 | Active |
| US9018175B2 | 3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives | Human Necessities | 1 | Active |
| US8304436B2 | Pyrazolone derivatives as PDE4 inhibitors | Human Necessities | 1 | Active |
| US8609848B2 | Pyrazolone-derivatives and their use as PDE-4 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7589205B2 | 3-thia-10-aza-phenanthrene derivatives | Human Necessities | 1 | Expired |
| US8865745B2 | Pyrazolone derivatives as PDE4 inhibitors | Human Necessities | 0 | Active |
| US9340522B2 | Pyrazolone-derivatives and their use as PDE-4 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9090597B2 | Pyrazolone derivatives as PDE4 inhibitors | Human Necessities | 0 | Active |
| US8648100B2 | Roflumilast for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.